All Insights White Paper Designing Incentive Compensation Plans For Specialty Products

    Designing Incentive Compensation Plans For Specialty Products

    Incentive Compensation

    Designing Incentive Compensation Plans For Specialty Products

    Key challenges in designing IC plans for promoting specialty drugs and recommended best practices.

    Download White Paper
    Designing Incentive Compensation Plans For Specialty Products

    The pharmaceutical industry is undergoing a significant transformation - shifting away from the development of blockbuster drugs to a more value-driven approach based, increasingly, on specialty medicines for niche markets and patient outcomes. For the commercial operations landscape, specialty medicines come with their own specific challenges across data integration and data coverage. Further, procuring market data is also difficult and cost-prohibitive, leading to unreliable specialty product forecasts, both of which limit the components used for incentive compensation to product-based sales and activity objectives.

    The focus of this white paper is to highlight key challenges in designing incentive compensation plans for promoting specialty drugs by a pharmaceutical sales force and the recommended best practices when approaching them.

    Contact us at insights@axtria.com with any questions.

    Click here to learn more about our Incentive Compensation Capabilities.

    Learn More linkClick Here To Learn More About Axtria Incentive Compensation Benchmarking Study – 2020 Results

    Complete the brief form to download the white paper

    Recommended insights

    Incentive Compensation Plans For Specialty Drugs

    Report

    2023 Alignment Design and Refinement Benchmarking Study

    Incentive Compensation Plans For Specialty Drugs

    Report

    2023 Global (Ex-US) Incentive Compensation Benchmarking Study

    Incentive Compensation Plans For Specialty Drugs

    Report

    2023 US Incentive Compensation Benchmarking Study